169 related articles for article (PubMed ID: 21605663)
41. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism.
Wiencke JK; Spitz MR; McMillan A; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):87-92. PubMed ID: 9037558
[TBL] [Abstract][Full Text] [Related]
42. An association between a NQO1 genetic polymorphism and risk of lung cancer.
Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
[TBL] [Abstract][Full Text] [Related]
43. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
44. Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.
Fleming RA; Drees J; Loggie BW; Russell GB; Geisinger KR; Morris RT; Sachs D; McQuellon RP
Pharmacogenetics; 2002 Jan; 12(1):31-7. PubMed ID: 11773862
[TBL] [Abstract][Full Text] [Related]
45. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
[TBL] [Abstract][Full Text] [Related]
46. Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis.
Malik MA; Zargar SA; Mittal B
Mol Biol Rep; 2012 Sep; 39(9):9095-104. PubMed ID: 22736108
[TBL] [Abstract][Full Text] [Related]
47. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
[TBL] [Abstract][Full Text] [Related]
48. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
[TBL] [Abstract][Full Text] [Related]
49. Involvement of NAD(P)H:quinone oxidoreductase 1 and superoxide dismutase polymorphisms in ulcerative colitis.
Kosaka T; Yoshino J; Inui K; Wakabayashi T; Kobayashi T; Watanabe S; Hayashi S; Hirokawa Y; Shiraishi T; Yamamoto T; Tsuji M; Katoh T; Watanabe M
DNA Cell Biol; 2009 Dec; 28(12):625-31. PubMed ID: 19715479
[TBL] [Abstract][Full Text] [Related]
50. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
51. Analysis of the C609T polymorphism of NQO1 gene in South Croatian patients with hematological malignancies.
Lozić B; Primorac D; Glavinić R; Samija RK; Zemunik T
Coll Antropol; 2011 Jun; 35(2):385-8. PubMed ID: 21755707
[TBL] [Abstract][Full Text] [Related]
52. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.
Mandal RK; Dubey S; Panda AK; Mittal RD
Tumour Biol; 2014 Jul; 35(7):6415-23. PubMed ID: 24676794
[TBL] [Abstract][Full Text] [Related]
53. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
[TBL] [Abstract][Full Text] [Related]
54. Analysis of NQO1 polymorphisms and p53 protein expression in patients with hepatocellular carcinoma.
Chiu MM; Ko YJ; Tsou AP; Chau GY; Chau YP
Histol Histopathol; 2009 Oct; 24(10):1223-32. PubMed ID: 19688691
[TBL] [Abstract][Full Text] [Related]
55. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease.
Fong CS; Wu RM; Shieh JC; Chao YT; Fu YP; Kuao CL; Cheng CW
Clin Chim Acta; 2007 Mar; 378(1-2):136-41. PubMed ID: 17188257
[TBL] [Abstract][Full Text] [Related]
56. Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.
Li C; Zhou Y
J Cancer Res Clin Oncol; 2014 Jun; 140(6):873-81. PubMed ID: 24488035
[TBL] [Abstract][Full Text] [Related]
57. Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian women.
Singh V; Upadhyay G; Rastogi N; Singh K; Singh MP
Genet Test Mol Biomarkers; 2011 May; 15(5):343-9. PubMed ID: 21329464
[TBL] [Abstract][Full Text] [Related]
58. [Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer].
Zhang WC; Yin LH; Pu YP; Liang GY; Hu X; Liu YZ; Cui YS
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):324-7. PubMed ID: 17166422
[TBL] [Abstract][Full Text] [Related]
59. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
60. NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
Basu S; Brown JE; Flannigan GM; Gill JH; Loadman PM; Martin SW; Naylor B; Puri R; Scally AJ; Seargent JM; Shah T; Phillips RM
Int J Oncol; 2004 Oct; 25(4):921-7. PubMed ID: 15375541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
